The absence of a matching report should not be interpreted as independent verification
A 2024 Science Advances paper from Christian Hendershot and colleagues tested semaglutide in 48 adults with alcohol use disorder over 9 weeks and found significant reductions in alcohol consumption, craving, and heavy drinking days, along with reductions in cigarette craving as a bonus endpoint
Change is possible, and it is working its way through Congress
Trial highlights: - Weight reduction: Patients achieved up to ~24% mean body weight loss at 48 weeks
[19] See also [edit] References [edit] 1 2 3 4 al
Activated microglia drive the immune response to the inflammatory state releasing immune signaling molecules (cytokines, and chemokines), and inducing neuronal cell death ( These data underline the importance of optimal glycemic control and call for major pharmacological interventions to reduce the risk of cardiometabolic-related cognitive impairment